Capital Fund Management S.A. Penumbra Inc Call Options Transaction History

Capital Fund Management S.A.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$220.09 - $273.15 $2.91 Million - $3.61 Million	-13,200 Reduced 52.59%	11,900 $2.66 Million
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $163,296 - $234,198	900 Added 3.72%	25,100 $6.31 Million
Q3 2023 Nov 14, 2023	BUY	$240.69 - $338.77 $5.82 Million - $8.2 Million	24,200 New	24,200 $5.85 Million

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.